BlackRock’s Compass Therapeutics CMPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.7M Sell
6,413,133
-695,957
-10% -$1.81M ﹤0.01% 3091
2025
Q1
$13.5M Buy
7,109,090
+221,475
+3% +$421K ﹤0.01% 3122
2024
Q4
$9.99M Buy
6,887,615
+67,163
+1% +$97.4K ﹤0.01% 3385
2024
Q3
$12.5M Buy
6,820,452
+206,815
+3% +$381K ﹤0.01% 3247
2024
Q2
$6.61M Buy
6,613,637
+581,171
+10% +$581K ﹤0.01% 3532
2024
Q1
$11.9M Sell
6,032,466
-189,843
-3% -$376K ﹤0.01% 3205
2023
Q4
$9.71M Buy
6,222,309
+248,574
+4% +$388K ﹤0.01% 3342
2023
Q3
$11.8M Sell
5,973,735
-58,557
-1% -$115K ﹤0.01% 3190
2023
Q2
$19.2M Buy
6,032,292
+4,491,397
+291% +$14.3M ﹤0.01% 2996
2023
Q1
$5.04M Buy
1,540,895
+303,114
+24% +$991K ﹤0.01% 3558
2022
Q4
$6.23M Buy
1,237,781
+365,284
+42% +$1.84M ﹤0.01% 3559
2022
Q3
$1.99M Buy
872,497
+709,071
+434% +$1.62M ﹤0.01% 4117
2022
Q2
$433K Buy
+163,426
New +$433K ﹤0.01% 4722